Big Gain For Vincerx Pharma Inc.
Tue, Mar 19, 2024 at 07:28 PM
Vincerx Pharma Inc. (VINC:NASDAQ) rocketted at $6.3, representing a gain of 28.3%. On Tue, Mar 19, 2024, VINC:NASDAQ touched a New 2-Week Intraday Low of $4.87. The stock got featured on our News Catalysts scanner on Thu, Mar 14, 2024 at 12:17 PM in the 'BIOTECH' category. From Tue, Mar 05, 2024, the stock recorded 60.00% Up Days and 54.55% Green Days
The stock spiked on Mon, Mar 11, 2024 at $9.37 with a volume of 1M+.
About Vincerx Pharma Inc. (VINC:NASDAQ)
Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of...
Top 10 Gainers:
- Ontrak Inc. (OTRK:NASDAQ), 131.58%
- Fusion Pharmaceuticals Inc. (FUSN:NASDAQ), 99.06%
- SCWorx Corp. (WORX:NASDAQ), 53.51%
- Sarcos Technology and Robotics Corporation (STRC:NASDAQ), 40.38%
- Enliven Therapeutics Inc Com (ELVN:NASDAQ), 38.77%
- Puyi Inc. (PUYI:NASDAQ), 33.93%
- BitFuFu Inc. (FUFU:NASDAQ), 32.35%
- Critical Metals Corp. (CRML:NASDAQ), 31.04%
- Vincerx Pharma Inc. (VINC:NASDAQ), 28.31%
- Actinium Pharmaceuticals, Inc. (ATNM:NYSEMKT), 25.54%